[Refractory perineal fistulas in Crohn's disease].
Atienza
Patrick
P
Service de Proctologie Médico-Interventionnelle, Groupe Hospitalier Diaconesses-Croix Saint Simon, Paris, France. nedpa@noos.fr
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000628:therapy; D017577:Cutaneous Fistula / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D019160:Endosonography; D005260:Female; D006801:Humans; D006931:Hyperbaric Oxygenation; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D010502:Perineum; D016032:Randomized Controlled Trials as Topic; D012003:Rectal Fistula / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D012006:Rectovaginal Fistula / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D008795:Metronidazole; D002939:Ciprofloxacin; D000069285:Infliximab; D016559:Tacrolimus